History of Sabin attenuated poliovirus oral live vaccine strains |
| |
| Affiliation: | 1. Fogarty International Centre, National Institutes of Health, Bethesda, Maryland 20014, U.S.A.;2. National Institute for Medical Research (Hampstead Laboratories), Holly Hill, London NW3 6RB, England;1. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts;2. Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;3. Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;1. Fundación Dominicana de Perinatologia Pro Bebe, Hospital Universitario Maternidad Nuestra Señora de la Altagracia, Santo Domingo, Dominican Republic;2. Clínica Cruz Jiminián, Santo Domingo, Dominican Republic;3. Bill & Melinda Gates Foundation, Seattle, WA, USA;4. Seattle, WA, USA;5. Centers for Disease Control and Prevention, Atlanta, GA, USA;6. VaxTrials, Panama City, Panama;7. Fighting Infectious Diseases in Emerging Countries, Miami, FL, USA;1. Departmentof Health Sciences, University of Genoa, Genoa, Italy;2. UNESCOCHAIR “Anthropology of Health - Biosphere and Healing System” - University of Genoa, Genoa, Italy;3. University Museum System of Siena (Simus), History of Medicine, University of Siena, Siena, Italy |
| |
| Abstract: | The full data concerning the history of attenuated poliovirus strains developed by one of us (Sabin, 1965) for vaccine production do not appear in a single journal. Over the past few years we have had frequent requests for the details such as isolation and attenuation and accordingly we felt that bringing the data together in the report below would be both helpful and informative to those involved in the production and control of poliovirus vaccine (oral) prepared from these strains. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
